Our pandemic podcast is ending, though the pandemic hasn’t ended around the world.
Things are starting to look up, at least in the U.S., but we’re looking ahead at potential future worries.
Lots of your questions about the future after COVID-19 get answered, and one listener gives us a little history lesson.
The Atlantic staff writer Ed Yong talks with James Hamblin and Maeve Higgins about the ways, large and small, in which we’ve all suffered.
What difference could it make worldwide if the U.S. waived patents for vaccines?
A long-COVID patient and an immunologist help us understand the mysterious condition.
“One country’s crisis is every country’s crisis.”
The rules need to change after vaccination. But carefully.
What the “pause” in Johnson & Johnson vaccinations means
Vaccine passports, explained
A medical historian explains how we got to this point—and where we need to go from here.
James Hamblin answers questions from callers with mild COVID-19 cases.
Why have the economic and psychological stresses of the pandemic hit women harder—and what can we do about it?
Vaccines are a public good. Until the world regards them as such, the pandemic will not end.
The Brazil variant raises a scary question—and reminds us that herd immunity matters across borders.
Or is it still risky to be optimistic?
A bioethics expert on the moral questions facing our vaccine rollouts.
How bad are the new COVID-19 variants, really?
We’re behind, but that may change quickly.
We’re very relieved, but now entering the strange time of vaccine purgatory.